CAS: 152529-79-8 - 4-(2,3,6,9-Tetrahydro-2,6-dioxo-1-propyl-1H-purin-8-yl)benzenesulfonic acid
Formula:C14H14N4O5S
InChI:InChI=1S/C14H14N4O5S/c1-2-7-18-13(19)10-12(17-14(18)20)16-11(15-10)8-3-5-9(6-4-8)24(21,22)23/h3-6H,2,7H2,1H3,(H,15,16)(H,17,20)(H,21,22,23)
InChI key:InChIKey=UYDRRQPGDSIMNU-UHFFFAOYSA-N
SMILES:O=C1NC=2N=C(NC2C(=O)N1CCC)C=3C=CC(=CC3)S(=O)(=O)O
- Synonyms:
- PSB 1115
- Benzenesulfonic acid, 4-(2,3,6,7-tetrahydro-2,6-dioxo-1-propyl-1H-purin-8-yl)-
- 4-(2,3,6,9-Tetrahydro-2,6-dioxo-1-propyl-1H-purin-8-yl)benzenesulfonic acid
- Benzenesulfonic acid, 4-(2,3,6,9-tetrahydro-2,6-dioxo-1-propyl-1H-purin-8-yl)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1-PROPYL-1H-PURIN-8-YL)-BENZENESULFONIC ACID REF: IN-DA00APUCCAS: 152529-79-8 | 98% | To inquire | Tue 12 Nov 24 | |
PSB 1115 REF: 3D-CGA52979CAS: 152529-79-8 | Min. 95% | To inquire | Fri 27 Dec 24 | |
PSB 1115 REF: TM-T23201CAS: 152529-79-8 | 100% - 99.24% | To inquire | Tue 28 Jan 25 |
4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1-PROPYL-1H-PURIN-8-YL)-BENZENESULFONIC ACID
CAS:152529-79-8
Formula:
C14H14N4O5S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
350.3498
Ref: IN-DA00APUC
5mg | 170.00 € | ||
10mg | 319.00 € | ||
25mg | 631.00 € | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 12 Nov 2024
PSB 1115
CAS:152529-79-8
PSB 1115 is a small-molecule compound that has been shown to inhibit the p2 receptor …
Formula:
C14H14N4O5S
Purity:
Min. 95%
Molecular weight:
350.35 g/mol
Ref: 3D-CGA52979
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
PSB 1115
CAS:152529-79-8
PSB 1115 is an A2B receptor antagonist and can counteract the inhibitory effect of NECA.
Formula:
C14H14N4O5S
Purity:
100% - 99.24%
Color and Shape:
Solid
Molecular weight:
350.35
Ref: TM-T23201
1mg | 66.00 € | ||
5mg | To inquire |
Estimated delivery in United States, on Tuesday 28 Jan 2025